Anabolic androgenic steroid use in recreational gym users: a regional sample of the Mid-Glamorgan area

References

• Brower K, Blow F, Young J and Hill E (1991) Symptoms and correlates of anabolic androgenic steroid dependence. British Journal of Addiction 86: 759–68.
   PubMedGoogle Scholar
• Buckley W, Yesalis C, Friedl K, Anderson W et al. (1988) Estimated prevalence of anabolic steroid use among male high-school seniorsjourna/ of the American Medical Association 260 (23): 3441–5.
   Google Scholar
• Burton C (1996) Anabolic steroid use among the popula-tion in Clwyd. Pharm aceutical Journal 256: 557–9.
   Google Scholar
• Donoghue M, Dolan K and Stimson GV (1991) The 1989-1990 National Syringe Monitoring Study. The Centre for Research on Drugs and Health Behaviour: London.
   Google Scholar
• DuRant R, Rickert V. Ashworth C et al. (1993) Use of multiple drugs among adolescents who use anabolic steroids. New England Journal of Medicine 328 (13): 922–6.
   PubMed Web of Science ®Google Scholar
• Evans N (1997) Gym and tonic: a profile of 100 male steroid users. BritishJoumal of Sports Medicine 31: 54–8.
   PubMed Web of Science ®Google Scholar
• Goldberg L, MacKinnon DP, Elliot DL, Moe EL et al. (2000) The (ATLAS) Adolescents Training and Learning to Avoid Steroids program: preventing drug use and promoting health behaviors. Archives of Pediatrics and Adolescent Medicine 151 (4): 332–8.
   Google Scholar
• Greenway P and Greenway M (1997) General practitioner knowledge of prohibited substances in sport. British Journal of Sports Medicine 31: 129–31.
   PubMedGoogle Scholar
• Hurst R, Hale B, Smith D and Collins D (2000) Exercise dependence, social physique anxiety, and social support in experienced and inexperienced body-builders and weightlifters. British Journal of Sports Medicine 34 (6): 431–5.
   PubMed Web of Science ®Google Scholar
• Korkia P and Stimson GV (1993) Anabolic Steroid Use In Great Britain: An exploratory investigation. The Centre for Research on Drugs and Health Behaviour: London.
   Google Scholar
• Lenehan P and McVeigh J (1994) HIV and steroid use. Relay 2: 1.
   Google Scholar
• Lenehan P. Bellis M and McVeigh J (1996) Anabolic steroid use in the North West of England. The Drugs and Sport Information Service: Liverpool.
   Google Scholar
• Liddle GW and Bourke HA Jr (1960) Anabolic steroids and clinical medicine. Helvetica Medica Acta 27: 505–13.
   Google Scholar
• McClain W and Bucci K (1988) Anabolic steroid use as an AIDS risk factor. Clinical Pharmacy 7: 95.
   PubMedGoogle Scholar
• McKillop G (1987) Drug abuse in bodybuilders in the West of Scotland. Scottish Medical Journal 32: 39–41.
   PubMed Web of Science ®Google Scholar
• Midgley SJ, Heather N, Best D, Henderson D, McCarthy S and Davies JIB (2000) Risk behaviours for HIV and hepatitis infection among anabolic androgenic steroid users. AIDS Care 12 (2): 163–70.
   PubMed Web of Science ®Google Scholar
• Mottram DR and George AJ (2000) Anabolic steroids. Best Practice & Research in Clinical Endocrinology & Metabolism 14 (1): 55–69.
   PubMed Web of Science ®Google Scholar
• Pates R and Barry C (1996) Steroid use in Cardiff a problem for whom? The Journal of Ped.ormance Enhan-cing Drugs 1 (3): 92–7.
   Google Scholar
• Perry H and Littlepage B (1992) Dying to be big: a review of anabolic steroid use. British Journal of Sports Medicine 4 (26): 259–61.
   Google Scholar
• Plowright S (1993) Harm Minimisation and Anabolic Steroids. Results and Recommendations of the DRIC Injecting Steroid User Survey. Assisting Drug Dependants Inc.: Canberra.
   Google Scholar
• Pope HG, Katz DL and Champoux R (1988) Affective and psychotic symptoms associated with anabolic steroid use. American Journal of Psychiatry 145: 487–90.
   PubMed Web of Science ®Google Scholar
• Rich JD (1995) A forgotten risk. Scientific American (Letter) p. 8.
   Google Scholar
• Rogol AD and Yesalis CE (1992) Anabolic androgenic steroids and athletes: what are the issues? Journal of Endocrinology and Metabolism 74: 465–9.
   Google Scholar
• Scott MJ and Scott MJ Jr (1989) HIV infection associated with injections of anabolic steroids. Journal of the American Medical Association 262 (2): 207–8.
   PubMed Web of Science ®Google Scholar
• Sklarek HM, Mantovani RP, Erens E et al. (1984) Aids in a bodybuilder using anabolic steroids. New England Journal of Medicine 311 (26): 1701.
   PubMed Web of Science ®Google Scholar
• Stimson GV, Keene J, Parry-Langton N et al. (1991) Evaluation of the syringe-exchange programme in Wales, 1990-1991. Final report to the Welsh Office. The Centre for Research on Drugs and Health Behaviour: London.
   Google Scholar
• Strawford A, Barbieri T, Van Loan M et al. (1999) Resistance exercise and supraphysiological androgen therapy in eugonadal men with HIV-related weight loss: a randomised trial. Journal of the American Medical Association 281 (14): 1282–90.
   PubMed Web of Science ®Google Scholar
• Wand Black A (1987) Pervasive anabolic steroid use among health club athletes. Annals of Sports Medicine 3 (3): 155–9.
   Google Scholar
• Tricker R, O'Neill M and Cook D (1989) The incidence of anabolic steroid use among competitive bodybuilders. Journal of Drug Education 19: 313–25.
   Google Scholar
• Wadler G and Hainline H (1989) Anabolic steroids. In: Ryan A (ed) Drugs and the Athlete. Contemporary Exercise and Sports Medicine Series. Davis Company: Philadelphia, USA.
   Google Scholar
• Williamson D (1991) Edinburgh's lesser known drug problems. Edinburgh Medicine 65: 6–7.
   Google Scholar
• Williamson D (1993) Misuse of anabolic drugs. British Medical Journal 6869 (306): 61.
   Google Scholar
• Windsor R and Dumitru D (1989) Prevalence of anabolic steroid use by male and female adolescents. Medicine and Science in Sports and Exercise 21(5): 494–7.
   PubMed Web of Science ®Google Scholar
• Yesalis CE and Bahrke MS (2000) Doping among adolescent athletes. Baillieres Best Practice and Research in Clinical Endocrinology and Metabolism 14 (1): 25–35.
   PubMed Web of Science ®Google Scholar
• Yesalis C, Herrick R, Buckley W et al. (1988) Self-reported use of anabolic androgenic steroids by elite powerlifters. The Physician and Sportsmedicine 16: 91–100.
   PubMed Web of Science ®Google Scholar